Here we present the first genome wide, arrayed guide RNA screening libraries for CRISPR-Cas9. These libraries have been designed to cover 17166 human and 20430 mouse genes. To test the efficiency, we selected gRNAs targeting genes from the GPI anchor protein pathway. We observed that over 95% of these gRNAs successfully induced DNA cleavage and consequently gene loss of function. These libraries offer the prospect for performing high-throughput screens for genes of considerable scientific and therapeutic value in mouse and human cells.
Emmanouil Metzakopian, Ph.D.
Wellcome Trust Sanger Institute
WTSI Career Development Fellow PDUK Senior Research Fellow
Dr. Metzakopian is a research fellow at Wellcome Trust Sanger Institute, where he focuses on identifying genes which confer resistance to chemotherapy drugs in embryonic stem cells and to oxidative stress agents in dopamine neurons.
Shawn Shafer, Ph.D.
Advanced Genomics Market Segment Manager
Dr. Shafer leads a team responsible for product development of Merck’s RNAi and genome editing portfolios. He orchestrated the creation of Merck CRISPR collection of reagents.
Session 1:presented May 12, 2016
To continue reading please sign in or create an account.Don't Have An Account?